These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 30630993

  • 1. Non-Small Cell Lung Carcinoma in Women: A Retrospective Cohort Study in Indonesia.
    Sutandyo N, Suratman E.
    Acta Med Indones; 2018 Oct; 50(4):291-298. PubMed ID: 30630993
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.
    Kim YT, Seong YW, Jung YJ, Jeon YK, Park IK, Kang CH, Kim JH.
    J Thorac Oncol; 2013 Feb; 8(2):171-8. PubMed ID: 23287850
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation.
    Barquín M, Calvo V, García-García F, Nuñez B, Sánchez-Herrero E, Serna-Blasco R, Auglytė M, Carcereny E, Rodriguez-Abreu D, López Castro R, Guirado M, Camps C, Bosch-Barrera J, Massuti B, Ortega AL, Del Barco E, Gonzalez-Larriba JL, Aguiar D, García-Campelo R, Dómine M, Agraso S, Sala MA, Oramas J, Bernabé R, Blanco R, Parejo C, Cruz A, Menasalvas E, Royuela A, Romero A, Provencio M.
    Cancer Epidemiol; 2020 Aug; 67():101737. PubMed ID: 32450544
    [Abstract] [Full Text] [Related]

  • 10. Gender Differences in Long-Term Survival after Surgery for Non-Small Cell Lung Cancer.
    Yoshida Y, Murayama T, Sato Y, Suzuki Y, Saito H, Nomura Y.
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):507-14. PubMed ID: 26366891
    [Abstract] [Full Text] [Related]

  • 11. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
    Izar B, Sequist L, Lee M, Muzikansky A, Heist R, Iafrate J, Dias-Santagata D, Mathisen D, Lanuti M.
    Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
    [Abstract] [Full Text] [Related]

  • 12. Serum MiRNA as Predictive and Prognosis Biomarker in Advanced Stage Non-small Cell Lung Cancer in Indonesia.
    Hanafi AR, Jayusman AM, Alfasunu S, Sadewa AH, Pramono D, Heriyanto DS, Haryana SM.
    Zhongguo Fei Ai Za Zhi; 2020 May 20; 23(5):321-332. PubMed ID: 32283582
    [Abstract] [Full Text] [Related]

  • 13. Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas.
    Guerrera F, Renaud S, Tabbó F, Voegeli' AC, Filosso PL, Legrain M, Boita M, Schaeffer M, Beau-Faller M, Ruffini E, Falcoz PE, Inghirami G, Oliaro A, Massard G.
    Eur J Cardiothorac Surg; 2017 Apr 01; 51(4):680-688. PubMed ID: 28329143
    [Abstract] [Full Text] [Related]

  • 14. Epidermal growth factor receptor mutation is associated with longer local control after definitive chemoradiotherapy in patients with stage III nonsquamous non-small-cell lung cancer.
    Yagishita S, Horinouchi H, Katsui Taniyama T, Nakamichi S, Kitazono S, Mizugaki H, Kanda S, Fujiwara Y, Nokihara H, Yamamoto N, Sumi M, Shiraishi K, Kohno T, Furuta K, Tsuta K, Tamura T.
    Int J Radiat Oncol Biol Phys; 2015 Jan 01; 91(1):140-8. PubMed ID: 25442336
    [Abstract] [Full Text] [Related]

  • 15. Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.
    Yao ZH, Liao WY, Ho CC, Chen KY, Shih JY, Chen JS, Lin ZZ, Lin CC, Chih-Hsin Yang J, Yu CJ.
    Oncologist; 2017 Sep 01; 22(9):1075-1083. PubMed ID: 28507206
    [Abstract] [Full Text] [Related]

  • 16. Trends and Outcomes of Non-Small-Cell Lung Cancer in Omani Patients: Experience at a university hospital.
    Furrukh M, Kumar S, Zahid KF, Al-Shamly HS, Al-Jabri ZA, Burney IA, Al-Moundhri MS.
    Sultan Qaboos Univ Med J; 2017 Aug 01; 17(3):e301-e308. PubMed ID: 29062552
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell lung cancer harboring EGFR mutations.
    Aiko N, Shimokawa T, Miyazaki K, Misumi Y, Agemi Y, Ishii M, Nakamura Y, Yamanaka T, Okamoto H.
    BMC Cancer; 2018 Oct 22; 18(1):1012. PubMed ID: 30348116
    [Abstract] [Full Text] [Related]

  • 18. The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations.
    Lin JH, Lin D, Xu L, Wang Q, Hu HH, Xu HP, He ZY.
    Oncotarget; 2017 Jan 10; 8(2):3412-3421. PubMed ID: 27926500
    [Abstract] [Full Text] [Related]

  • 19. Histology and smoking status predict survival of patients with advanced non-small-cell lung cancer. Results of West Japan Oncology Group (WJOG) Study 3906L.
    Kogure Y, Ando M, Saka H, Chiba Y, Yamamoto N, Asami K, Hirashima T, Seto T, Nagase S, Otsuka K, Yanagihara K, Takeda K, Okamoto I, Aoki T, Takayama K, Yamasaki M, Kudoh S, Katakami N, Miyazaki M, Nakagawa K.
    J Thorac Oncol; 2013 Jun 10; 8(6):753-8. PubMed ID: 23575412
    [Abstract] [Full Text] [Related]

  • 20. Post-recurrence survival analysis of stage I non-small-cell lung cancer.
    Lee K, Kim HR, Kim DK, Kim YH, Park SI, Choi SH, Han J.
    Asian Cardiovasc Thorac Ann; 2017 Nov 10; 25(9):623-629. PubMed ID: 29058973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.